Sen. Bernie Sanders is facing sharp criticism from lawmakers on both sides of the aisle after obstructing a bipartisan bill aimed at expanding funding for pediatric cancer research.
The legislation, which had support from members of both parties, was designed to increase federal investment in studies targeting childhood cancers and improve access to cutting-edge treatments for young patients. Supporters said the measure’s broad backing reflected a rare area of consensus in Congress.
During a procedural vote, Sanders voted against advancing the bill, prompting frustration from colleagues who had worked across party lines to craft the proposal. Critics accused him of standing in the way of urgently needed research funding and slowing momentum on a health issue affecting families nationwide.
Sanders’ office defended the vote, saying he had concerns about specific elements of the measure, including provisions tied to broader budgetary priorities. He suggested that additional work was needed to ensure the legislation met long-term goals without creating unintended financial consequences.
Despite the setback, sponsors of the bill said they plan to re-work the language and pursue alternative avenues to secure support, emphasizing the continuing need for federal commitment to pediatric cancer research.
The episode underscores ongoing challenges in advancing health care legislation even when there is visible bipartisan agreement on the importance of the cause. Lawmakers on both sides reiterated their intention to keep pressing for action that benefits children battling cancer.